fbpx

Diagnosed With Pancreatic Cancer?

In order to thrive, you need to have all of the tools at your fingertips, and that includes evidence-based therapies that go beyond conventional oncology.

Download our FREE PDF guide filled with evidence-based therapies that you can start today to manage your Pancreatic Cancer. Click the orange button to get your download now.

Electromagnetic Fields for Pancreatic Cancer

Share Button

Cancer-related frequencies appear to be tumor-specific and treatment with tumor-specific frequencies is feasible, well-tolerated and may have biological efficacy in patients with advanced Pancreatic Cancer.

Pancreatic cancer that has metastasized is almost impossible to treat. If fact, I don’t believe that conventional oncology has any real therapies for it. A partial-response of four months may not look like much but keep in mind that this therapy comes with no NCI grade 2,3 or 4 side effects.

The challenge for the cancer patient is to find a practitioner of this admittedly alternative cancer therapy.

I am both a cancer survivor and cancer coach. While my cancer is completely different from pancreatic cancer both cancers share the fact that conventional oncology considers them to be “incurable.”

I work with cancer patients to identify all possible treatment options for all types of cancer at any stage.

Please take a moment to watch the short video below in order to learn more about some of these evidence-based therapies that can help you manage your Pancreatic Cancer:

 

Scroll down the page to ask a question or make a comment.

Thank you,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach.

“Purpose-Because in vitro studies suggest that low levels of electromagnetic fields may modify cancer cell growth, we hypothesized that systemic delivery of a combination of tumor-specific frequencies may have a therapeutic effect. We undertook this study to identify tumor-specific frequencies and test the feasibility of administering such frequencies to patients with advanced cancer.

Patients and methods
We examined patients with various types of cancer using a noninvasive biofeedback method to identify tumor-specific frequencies. We offered compassionate treatment to some patients with advanced cancer and limited therapeutic options.

Results
We examined a total of 163 patients with a diagnosis of cancer and identified a total of 1524 frequencies ranging from 0.1 Hz to 114 kHz. Most frequencies (57–92%) were specific for a single tumor type. Compassionate treatment with tumor-specific frequencies was offered to 28 patients. Three patients experienced grade 1 fatigue during or immediately after treatment. There were no NCI grade 2, 3 or 4 toxicities.

Thirteen patients were evaluable for response:

  • One patient with hormone-refractory breast cancer metastatic to the adrenal gland and bones had a complete response lasting 11 months.
  • One patient with hormone-refractory breast cancer metastatic to liver and bones had a partial response lasting 13.5 months.
  • Four patients had stable disease lasting for +34.1 months (thyroid cancer metastatic to lung), 5.1 months (non-small cell lung cancer), 4.1 months (pancreatic cancer metastatic to liver) and 4.0 months (leiomyosarcoma metastatic to liver).

Conclusion-Cancer-related frequencies appear to be tumor-specific and treatment with tumor-specific frequencies is feasible, well tolerated and may have biological efficacy in patients with advanced cancer.

 

Leave a Comment: